Pierre Daubersies

Title: Pierre Daubersies: Innovator in Malarial Research

Introduction

Pierre Daubersies is a notable inventor based in Paris, France. He has made significant contributions to the field of malarial research, particularly in the development of polypeptide molecules that target the pre-erythrocytic stage of malaria. His work is crucial in the ongoing fight against this devastating disease.

Latest Patents

Pierre Daubersies holds 2 patents related to his research. His latest patents include innovations in malarial pre-erythrocytic stage polypeptide molecules. These patents disclose polypeptide molecules containing at least 10 consecutive amino acids of the amino acid sequence representing the LSA3 antigen. Additionally, they cover nucleic acids encoding the liver stage antigen, the LSA-3 immunogenic polypeptide, recombinant vectors containing these nucleic acids, and methods for producing the polypeptide using the nucleic acids and vectors.

Career Highlights

Pierre Daubersies is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution has positioned him as a key figure in the field of infectious diseases, particularly malaria.

Collaborations

Pierre Daubersies collaborates with fellow researcher Pierre Druilhe, enhancing the impact of their combined expertise in malarial research.

Conclusion

Pierre Daubersies is a dedicated inventor whose work in malarial research is paving the way for innovative solutions to combat malaria. His contributions are vital in the ongoing efforts to understand and treat this global health challenge.